Clinical Trials in Alexandria, New South Wales
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Urothelial Carcinoma
Seagen, a wholly owned subsidiary of Pfizer372 enrolled221 locationsNCT04879329
Recruiting
The AUS-PREDICT Registry for DCIS Patients With DCISionRT Testing
DCIS
PreludeDx1,500 enrolled2 locationsNCT04916808